New drug EPI-326 enters human testing for tough cancers
Disease control
Recruiting now
This early-stage study tests a new drug called EPI-326 in about 110 people with advanced lung cancer (with a specific EGFR gene change) or head and neck cancer. The main goal is to find a safe dose and check for side effects. Researchers will also measure drug levels in the blood…
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated May 13, 2026 16:02 UTC